In the pages of the Emerging Markets Report we are perpetually in search of novel ideas or technologies in a growth industry and with proven leadership.

Today’s feature certainly meets that criteria and then some. Frankly, we’re not sure we’ve covered a company in recent memory with the market potential of today’s topic. There is massive opportunity here. Just tremendous scale.

But it is different, very different. Hear us out.

CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN0),  is a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry.

That’s right. Lab grown meat. Let’s get that shocking little nugget out of the way. It’s not meat in the traditional sense. No cow, pig, or lamb has lent its meat to the eventual product offering.

Just its cells.

And before you get high and mighty about the notion of lab grown meat as if they are creating Frankenburgers from an unnatural process they’re not. Cellular agriculture is simply training cells to create meat in a predictable way, cultivated from the same sources we’ve relied on for millenia.

“Cell-cultivated meat is developed in a lab, grown from a sample of animal cells that does not require the slaughter of animals. Developing cell-cultivated meat involves five steps: (1) taking a biopsy of animal cells, (2) cell banking, (3) cell growth, (4) harvesting, and (5) food processing.”                                        Source: Congressional Research Service

CULT’s technology and those it is partnering with are producing meat and alternative proteins in a way that could dramatically help feed society, doesn’t harm animals, improves our health, and avoids the adverse impact traditional meat production has on the planet.

It’s a staggering concept, and one with a market appetite, pun intended, that is almost limitless. For us, this is to food production what A.I. is to technology or 3D printing is to manufacturing. The first mover advantage to major category disruptors can present huge opportunities. Look no further than Nvidia and Tesla to understand how critical it is to be ahead of the curve in sectors with massive tailwinds.

And with the aforementioned benefits to humans, animals and the environment.

We also love that the Company has products on the digital shelves already at no less than Wal-Mart, Kroger, Amazon and fifteen other online locations around the country. It’s their dog and cat food brand “Noochies!” which we see as a foot-in-the-door type deal, even if the pet food market is massive as well.

We think the market for lab grown meat is virtually limitless, given the insatiable human need for protein and a rising awareness about how traditional meats are obtained. These are the early stages for CULT for sure, but a stage that is well past proof-of-concept and baptized by deals with first tier online sales channels.

If the Company continues to innovate and execute, growing their revenue as they have cellular agriculture, a broader market will certainly take interest. Meanwhile, if the Company’s eventual human food finds broad acceptance, a food revolution could well be in the offing with one pioneering, opportunistic firm with a portfolio full of technology and able partners leading the way.

About CULT Food Science Corp.CULT Food Science is a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global good industry. CULT’s robust portfolio of investments in cutting-edge, venture-backed cellular agriculture and lab-grown meat companies provides widespread investor access to the future of food. Backed by a team of experts with extensive experience in food technology and launching consumer food products, CULT is committed to being at the forefront of the food revolution.

About The Emerging Markets Report:The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at https://emergingmarketsconsulting.com/alerts/

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.

EMC has been paid $75,000 by CULT Food Science Corp. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. | Please read our full disclaimer.

For media Inquiries contact:

Maggie Carawaymaggie@emergingmarketsconsulting.com